Rhabdomyolysis-induced acute renal failure following fenofibrate therapy: A case report and literature review


DANİŞ R., AKBULUT A. S., Ozmen S., Arikan S.

Case Reports in Medicine, cilt.2010, 2010 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 2010
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1155/2010/537818
  • Dergi Adı: Case Reports in Medicine
  • Derginin Tarandığı İndeksler: Scopus
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Fenofibrate, a fibric acid derivative, is used to treat diabetic dyslipidemia, hypertriglyceridemia, and combined hyperlipidemia, administered alone or in combination with statins. Rhabdomyolysis is defined as a pathological condition involving skeletalmuscle cell damage leading to the release of toxic intracellular material into circulation. Its major causes include muscle compression or overexertion; trauma; ischemia; toxins; cocaine, alcohol, and drug use; metabolic disorders; infections. However, rhabdomyolysis associated with fenofibrate is extremely rare. Herein we report a 45-year-old female patient who was referred to our department because of generalizedmuscle pain, fatigue, weakness, and oliguria over the preceding 3 weeks.On the basis of the pathogenesis and clinical and laboratory examinations, a diagnosis of acute renal failure secondary to fenofibrate-induced rhabdomyolysis wasmade. Weekly followups for patients who are administered fenofibrate are the most important way to prevent possible complications. Copyright © 2010 Ramazan Danis et al.